NBA Trade Rumors: Killing Them Softly

You never wish injury upon an NBA player (or any person), but the news today that the Cleveland Cavaliers’ Anderson Varejao will undergo surgery and be sidelined for two months could be a blessing in disguise. The report:

Varejao was the NBA’s leading rebounder when he injured his knee in a Dec. 18 game against Toronto. Team doctors believed it was only bruised, but when his symptoms persisted, further tests were done and revealed the tear. Varejao will have surgery on Thursday and the team said he is expected to be out at least six to eight weeks

Varejao had been expected to return to practice on Tuesday, when coach Byron Scott first indicated the center’s injury could be severe. It’s the third significant injury in three seasons for the scrappy Varejao, who missed 92 games over the past two seasons with a torn foot ligament and broken wrist.

It has been a rumor for some time that the Wolves were looking to the Cavs’ Varejao as an alternative to signing Nikola Pekovic. Pek is likely to fetch an over-priced offer sheet this offseason, and numerous limitations to finance and intelligence would seem to be causing the Wolves hesitation in committing to the best center in Wolves history, long-term.

Presumably, Andy V’s injury status changes those plans, but the motivation of the Wolves to find a capable big with the looming potential of Kevin Love’s season to be more-or-less lost if he requires surgery on his broken hand (and is out for 3 months), versus finding an above-average wing to help save the Wolves’ league-worst 3 point shooting — and provide some space for the bigs now existing on their roster to work with — is a philosophical question of direction and long-term vision that will say more about this franchise and management than any blue print, pledge or marketing scheme ever could.

Tags: Anderson Varejao Minnesota Timberwolves Nikola Pekovic

comments powered by Disqus